Advanced Medical Optics has reported a fourth-quarter $7.6m loss compared to a profit of $2.3m a year ago, mainly because of lower revenue related to a product recall.
The company recalled some 2.9m units of eye care products from Asia Pacific, Japan and US markets in November, following a production line issue at its plant in China, affecting fourth-quarter and full-year 2006 eye care sales by $25m. AMO anticipates losing an additional $20m to $25m in sales in 2007. Production for the European markets was uninterrupted as they are supplied by the company's facility in Spain.
Jim Mazzo, AMO chairman, president and CEO, said that the company made progress in establishing AMO as the refractive company. He added: 'We successfully repositioned our eye care business by streamlining our offering to focus on higher-margin products, while aggressively addressing the recall at the end of the year. In addition, we prepared to introduce a series of new products across each of our businesses in 2007.'
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here